In our latest whitepaper, study one shows BLIS K12™ reduces VSC – which are unpleasant odorous compounds produced by halitosis-causing bacteria.
Study two shows that when BLIS K12™ is used in conjunction with toothbrushing, flossing, and mouthwash, it reduces halitosis over longer periods of time.
Meet us at Vitafoods Asia 2024 where we will be presenting our latest probiotic innovations and clinical research.
We’re partnering with the IPA World Congress + Probiota Americas this June. Join us in Salt Lake City to dive into the world of microbiome science and business.
Upper respiratory illnesses, such as the common cold and flu, have a significant impact on our daily lives. To combat these upper respiratory illnesses naturally, a potential solution may be closer than you think: BLIS K12™. T
Gum disease (periodontitis) is one of the most prevalent chronic health conditions globally — yet it often goes undetected until it’s advanced.
Scientific innovation is a team effort, and at BLIS, we’re proud to have a diverse group of scientists driving our research forward.
Our whitepaper delves into the science of probiotics and their role in reshaping the way we manage autoimmune health.
